Search

Your search keyword '"Oxymorphone"' showing total 1,132 results

Search Constraints

Start Over You searched for: Descriptor "Oxymorphone" Remove constraint Descriptor: "Oxymorphone"
1,132 results on '"Oxymorphone"'

Search Results

Catalog

Books, media, physical & digital resources

3. In vivo photopharmacology with light-activated opioid drugs.

9. Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

11. Assessing the risks of abuse of opioids in real-world data

16. A preliminary study of hydrocodone and hydromorphone to oxycodone ratios for distinguishing impurities from independent opioid use.

20. Oxymorphone and Oxycodone Pharmacy Purchases in US Counties: Prelude to the Largest Rural Human Immunodeficiency Virus Outbreak in US History.

22. Declines and regional variation in opioid distribution by U.S. hospitals.

23. Opioids

28. Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes.

32. Oxycodone for pain management in the latent phase of labour - A pragmatic trial.

34. Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation.

35. Direct Chemiluminescence Determination of Oxymorphone Using Potassium Permanganate and Polyphosphoric Acid

43. Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases

44. Metabolic interactions of benzodiazepines with oxycodone ex vivo and toxicity depending on usage patterns in an animal model

45. A systematic analysis and data mining of opioid-related adverse events submitted to the FAERS database.

46. Oxycodone pharmacokinetics and fetal exposure after intravenous or epidural administration to the ewe.

47. Sex and Estrous Cycle Differences in Analgesia and Brain Oxycodone Levels

48. Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests

49. Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium/calmodulin-dependent protein kinase II signaling

50. Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes